"The question was never can we build this.
It was whether anyone would build it correctly."

ReLive Genomics was founded at the intersection of two fields that rarely speak to each other — computational biology and artificial intelligence. Most AI systems learn from text. We believe the more important dataset is the human body itself.

The founding insight was straightforward: existing approaches to biological AI preserve what a person said. They do not attempt to preserve what they were — their emotional patterns, their genomic predispositions, their physiological signature. No company had attempted to build a unified multi-omics personal embedding. So we decided to.

The architecture we are building is privacy-first by design — local preprocessing, user-governed review controls, and approved training workflows in ReLive datacenters, with the individual as the owner of their biological data. This is not a feature. It is the foundation every product we build will stand on.

ReLive Genomics is an early-stage company. We are building carefully because the problems we are working on — memory, longevity, biological identity — are not problems that reward speed over correctness. The research foundation is in place. The build has begun.